22 KB96 KB20 KB192920262003Maček, MacaMatoh Meglič, VeruškaMeden-Vrtovec, HelenaPinter, BojanaPretnar-Darovec, AlenkaRibič-Pucelj, MartinaVerdenik, Ivanletnik:72str. II-9-II12številka:supl. 2ISSN:1318-0347COBISSID:16660953URN:URN:NBN:SI:doc-YNXCMQKWslSlovensko zdravniško društvoZdravniški vestnikAge Of OnsetClimactericEstrogen Replacement TherapyEstrogen, nadomestno zdravljenjeKlimakterijMenopauseMenopavzaMenstrual CycleMenstrualni cikelMiddle AgeSloveniaSlovenijaSocial EnvironmentSocialno okoljeSrednja letaStarost pri obolevnostiwomanženskeMenopavza v Sloveniji| Menopause in Slovenia| women's characteristics and the frequency of perimenopausal symptoms| značilnosti žensk in pojavnost perimenopavznih simptomov|Background. We designed the study to determine the frequency of perimenopausalsymtoms among women in Slovenia and the need for their treatment. Methods. In the research 578 women aged 45-54 years were included during their visit at one of 24 participating outpatient department clinics for womens health in Slovenia. The women were interwieved by one of 31 gynecologists participating in the study. Results. The mean age of women was 49.6 years. Almost a half (48%) have still had regular periods, 29% were postmenopausal. The median age at menopause was 52.4 years. The major perimenopausal features were nervouseness (72%), anxiety (64%), sweating (63%), insomnia (60%) and headache (56%), less frequent were stomach pressure (35%), skin changes (32%) and dispareunia (24%). One-fifth (21%) of women weresmokers (smokers had lower age at menopause as non-smokers, p=0.01). One third (39%) currently took analgetics, 19% antihypertensives, 16% tranquillisers and 22% hormonal replacement therapy (HRT). The majority (81%) of women on HRT have found the HRT effects positive or very positive. Conclusions. The high rate of perimenopausal features among perimenopausal women in Slovenia deserves special attention. The study has also shown that the use of HRT is justified when indicatedIzhodišča. V raziskavi smo želeli ugotoviti pojavnost perimenopavznih simptomov med ženskami v Sloveniji in oceniti potrebo po zdravljenju simptomov. Metode. V raziskavo smo vključili 578 žensk, starih 45-54 let, ki so se odzvale na naše povabilo na anketiranju v času njihovega obiska pri izbranem ginekologu v letu 2000. V izpolnjevanju ankete je sodelovalo 31 ginekologov iz 24 dispanzerjev za ženske oz. ginekoloških ambulant v Sloveniji. Rezultati. Povprečna starost žensk je bila 49,6 let, skoraj polovica (48%) je še imela redne menstruacije, 29% pa jih je bilo v pomenopavzi. Srednja starost ob menopavzi je bila 52,4 let. Najpogostejši perimenopavzni simptomi so bili nervoznost (72%), zaskrbljenost (64%), znojenje (63%), nespečnost (60%) in glavobol (56%), redkeje pa tiščanje v želodcu (35%), spremembe na koži (32%) in dispareunija (24%). Petina (21%) žensk je bilo kadilk (kadilke so imele nižjo starost ob menopavzi kot nekadilke, p=0,01). Tretjina žensk (39%) je jemala analgetike, 19% antihipertenzive, 16% pomirjevala in 22% hormonsko nadomestno zdravljenje (HNZ). Večina žensk (81%), ki so kdajkoli jemale HNZ, je učinek HNZ ocenilo kot dober oz. zelo dober. Zaključki. Visok delež perimenopavznih simptomov medperimenopavznimi ženskami v Sloveniji zasluži posebno pozornost. Raziskava je pokazala, da je HNZ učinkovito pri odpravljanju perimenopavznih simptomovTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo